Live feed
Filing
SC 13G
SC 13G0000935836-19-000360·EcoR1 Capital, LLC
Schedule 13G ownership disclosure
Prevail Therapeutics Inc.
Security class unavailable · CUSIP: 74140Y101
Event date: 2019-06-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,392,556
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-19-000360
- Form type
- SC 13G
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- Jun 28, 2019
- Reporting period
- Jun 20, 2019
- Description
- Schedule 13G beneficial ownership